Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 352

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Induction of Immunoreactive Somatomedin C in Human Serum by Growth Hormone: Dose-Response Relationships and Effect on Chromatographic Profiles*

COPELAND, KENNETH C., UNDERWOOD, LOUIS E., VAN WYK, JUDSON J.·1980·The Journal of Clinical Endocrinology & Metabolism

Abstract

The induction of somatomedin C (SM-C) was evaluated in 30 hypopituitary patients and in normal subjects using a sensitive, specific RIA for SM-C. Two hypopituitary patients each received an iv bolus of 0.1 U human GH (hGH)⁄kg BW, followed by continuous infusion of 0.01 U hGH⁄kg-h for 12 h. The earliest rise in SM-C was detectable between 6-8 h. In response to the im administration of hGH, hypopituitary patients demonstrated a delay of 8 h before the rise in SM-C, a peak response between 16-28 h, and a fall nearly to basal levels by 48 h. The delay in the serum SM-C response to the administration of hGH suggests that SM is not stored in a readily releasable form and that the effect of GH on SM production may be through the stimulation of de novo synthesis. Graded doses of hGH in a sequence of 0.1, 0.2, 0.4, and 0.8 U/kg (im) elicited a stairstep pattern of SM-C response. When the sequence of administration of these doses was altered, however, it was apparent that the magnitude of the SM-C response was determined less by the dose of hGH employed than by the prior experience of the patient with hGH. When two identical doses of hGH were administered at 48-h intervals, the response to the second dose was uniformly greater than that to the first. Two of 28 hypopituitary children receiving hGH therapy failed to raise their SM-C levels out of the hypopituitary range and 6 other responses were subnormal. These noninducers were undernourished and had normal growth rates in spite of persistently low SM-C levels. Sephadex G-200 chromatography of the serum from 2 of these patients revealed neither an elevation in [125Ι]SM-C binding in the large 150,000 (150 K) mol wt region nor a significant increase in endogenous SM-C activity after hGH. This contrasts with the pattern seen in most hypopituitary patients in whom hGH causes a marked increase in endogenous activity in the 150 K region as well as the emergence of [125I]- SM-C binding in this region. From these results, it is concluded that the 150 K SM-binding complex is GH dependent and is a major determinant of the immunoreactive SM-C measured in native serum.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem-50-4-690

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 352

Metadata

Authors
COPELAND, K. C., UNDERWOOD, L. E., & VAN WYK, J. J.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1980-04
Volume
50
Issue
4
Pages
690-697
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1978916721
Cited by
352
References
10
FWCI
14.27
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Induction of Immunoreactive Somatomedin C in Human Serum by Growth Hormone: Dose-Response Relationships and Effect on Chromatographic Profiles*. https://app.cochat.ai/papers/10.1210/jcem-50-4-690
The paper
COPELAND, K. C., UNDERWOOD, L. E., & VAN WYK, J. J. (1980). Induction of Immunoreactive Somatomedin C in Human Serum by Growth Hormone: Dose-Response Relationships and Effect on Chromatographic Profiles*. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-50-4-690

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.